254 related articles for article (PubMed ID: 9658179)
21. Maintenance of Bone Homeostasis by DLL1-Mediated Notch Signaling.
Muguruma Y; Hozumi K; Warita H; Yahata T; Uno T; Ito M; Ando K
J Cell Physiol; 2017 Sep; 232(9):2569-2580. PubMed ID: 27735989
[TBL] [Abstract][Full Text] [Related]
22. Osteoclast-osteoblast communication.
Matsuo K; Irie N
Arch Biochem Biophys; 2008 May; 473(2):201-9. PubMed ID: 18406338
[TBL] [Abstract][Full Text] [Related]
23. [Stress and cell communication between bone cells].
Nakashima T
Clin Calcium; 2013 Nov; 23(11):1595-603. PubMed ID: 24162599
[TBL] [Abstract][Full Text] [Related]
24. Bone remodeling: Multiple cellular interactions required for coupling of bone formation and resorption.
Sims NA; Gooi JH
Semin Cell Dev Biol; 2008 Oct; 19(5):444-51. PubMed ID: 18718546
[TBL] [Abstract][Full Text] [Related]
25. Current insights into the role of transforming growth factor-beta in bone resorption.
Fox SW; Lovibond AC
Mol Cell Endocrinol; 2005 Nov; 243(1-2):19-26. PubMed ID: 16219413
[TBL] [Abstract][Full Text] [Related]
26. Cthrc1 is a positive regulator of osteoblastic bone formation.
Kimura H; Kwan KM; Zhang Z; Deng JM; Darnay BG; Behringer RR; Nakamura T; de Crombrugghe B; Akiyama H
PLoS One; 2008 Sep; 3(9):e3174. PubMed ID: 18779865
[TBL] [Abstract][Full Text] [Related]
27. Suberoylanilide hydroxamic acid (SAHA; vorinostat) causes bone loss by inhibiting immature osteoblasts.
McGee-Lawrence ME; McCleary-Wheeler AL; Secreto FJ; Razidlo DF; Zhang M; Stensgard BA; Li X; Stein GS; Lian JB; Westendorf JJ
Bone; 2011 May; 48(5):1117-26. PubMed ID: 21255693
[TBL] [Abstract][Full Text] [Related]
28. [Regulation of bone homeostasis by bone cells].
Nakashima T
Clin Calcium; 2013 Feb; 23(2):218-28. PubMed ID: 23354089
[TBL] [Abstract][Full Text] [Related]
29. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
Okamoto M; Murai J; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
[TBL] [Abstract][Full Text] [Related]
30. Bone morphogenetic protein type IA receptor signaling regulates postnatal osteoblast function and bone remodeling.
Mishina Y; Starbuck MW; Gentile MA; Fukuda T; Kasparcova V; Seedor JG; Hanks MC; Amling M; Pinero GJ; Harada S; Behringer RR
J Biol Chem; 2004 Jun; 279(26):27560-6. PubMed ID: 15090551
[TBL] [Abstract][Full Text] [Related]
31. The Role Of BMPs in the Regulation of Osteoclasts Resorption and Bone Remodeling: From Experimental Models to Clinical Applications.
Bordukalo-Nikšić T; Kufner V; Vukičević S
Front Immunol; 2022; 13():869422. PubMed ID: 35558080
[TBL] [Abstract][Full Text] [Related]
32. Osteoblastic heparan sulfate glycosaminoglycans control bone remodeling by regulating Wnt signaling and the crosstalk between bone surface and marrow cells.
Mansouri R; Jouan Y; Hay E; Blin-Wakkach C; Frain M; Ostertag A; Le Henaff C; Marty C; Geoffroy V; Marie PJ; Cohen-Solal M; Modrowski D
Cell Death Dis; 2017 Jun; 8(6):e2902. PubMed ID: 28661485
[TBL] [Abstract][Full Text] [Related]
33. Alendronate affects osteoblast functions by crosstalk through EphrinB1-EphB.
Shimizu E; Tamasi J; Partridge NC
J Dent Res; 2012 Mar; 91(3):268-74. PubMed ID: 22180568
[TBL] [Abstract][Full Text] [Related]
34. The Function of Wnt Ligands on Osteocyte and Bone Remodeling.
Du JH; Lin SX; Wu XL; Yang SM; Cao LY; Zheng A; Wu JN; Jiang XQ
J Dent Res; 2019 Jul; 98(8):930-938. PubMed ID: 31282847
[TBL] [Abstract][Full Text] [Related]
35. Osteoblast proliferation and differentiation on dentin slices are modulated by pretreatment of the surface with tetracycline or osteoclasts.
Schwartz Z; Lohmann CH; Wieland M; Cochran DL; Dean DD; Textor M; Bonewald LF; Boyan BD
J Periodontol; 2000 Apr; 71(4):586-97. PubMed ID: 10807123
[TBL] [Abstract][Full Text] [Related]
36. Streptococcus gordonii induces bone resorption by increasing osteoclast differentiation and reducing osteoblast differentiation.
Park OJ; Kim J; Kim HY; Kwon Y; Yun CH; Han SH
Microb Pathog; 2019 Jan; 126():218-223. PubMed ID: 30414445
[TBL] [Abstract][Full Text] [Related]
37. Control of bone mass and remodeling by PTH receptor signaling in osteocytes.
O'Brien CA; Plotkin LI; Galli C; Goellner JJ; Gortazar AR; Allen MR; Robling AG; Bouxsein M; Schipani E; Turner CH; Jilka RL; Weinstein RS; Manolagas SC; Bellido T
PLoS One; 2008 Aug; 3(8):e2942. PubMed ID: 18698360
[TBL] [Abstract][Full Text] [Related]
38. Matrix-embedded cells control osteoclast formation.
Xiong J; Onal M; Jilka RL; Weinstein RS; Manolagas SC; O'Brien CA
Nat Med; 2011 Sep; 17(10):1235-41. PubMed ID: 21909103
[TBL] [Abstract][Full Text] [Related]
39. TSG-6 regulates bone remodeling through inhibition of osteoblastogenesis and osteoclast activation.
Mahoney DJ; Mikecz K; Ali T; Mabilleau G; Benayahu D; Plaas A; Milner CM; Day AJ; Sabokbar A
J Biol Chem; 2008 Sep; 283(38):25952-62. PubMed ID: 18586671
[TBL] [Abstract][Full Text] [Related]
40. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
Hill PA; Reynolds JJ; Meikle MC
Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
